Synergy between histone deacetylase inhibitors and DNA-damaging agents is mediated by histone deacetylase 2 in colorectal cancer
Samer Alzoubi(Imperial College London), Nabil Hajji(Cancer Research Center)
Cited by 36
Related Papers
Histone Deacetylation Inhibition in Pulmonary Hypertension
|Circulation|2012|260
Histone Acetylation and Chemoresistance in Colorectal Cancer: an Opportunity for Effective Personalized Treatment
|Spiral (Imperial College London)|2013|1